Precancerous Bile Duct Pathology in End-stage Primary Sclerosing Cholangitis, With and Without Cholangiocarcinoma
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Patients with primary sclerosing cholangitis (PSC) are at increased risk for developing cholangiocarcinoma (CCA). However, the morphology of precursor lesions and the prevalence of biliary dysplasia among patients undergoing liver transplantation for PSC are incompletely defined, and the earlier studies using relatively small number of cases have yielded conflicting results. We retrospectively evaluated 100 consecutive formalin-fixed PSC liver explants (including 30 with CCA) by randomly sampling the hilar and large intrahepatic bile ducts (10 additional tissue cassettes submitted per case). The following histologic features were evaluated and quantitated according to the number of ducts involved: mucinous metaplasia, pyloric metaplasia, intestinal metaplasia, pancreatic acinar metaplasia, and biliary dysplasia [low-grade vs. high-grade (biliary intraepithelial neoplasia-2 or neoplasia-3), papillary vs. flat]. Using Fisher exact test and t test, these features were correlated with the presence or absence of CCA and with the following clinical parameters: sex, age, PSC duration, cirrhotic-stage liver disease, and inflammatory bowel disease at the time of transplant. We found high frequencies of mucinous metaplasia (77%), pyloric metaplasia (73%), and pancreatic acinar metaplasia (10%), which did not differ between CCA and non-CCA livers. However, livers with CCA were more likely to harbor intestinal metaplasia (43% vs. 19%, P=0.013), dysplasia (of any grade) (83% vs. 36%, P<0.0001), and high-grade dysplasia (60% vs. 11%, P<0.0001), and also contained greater numbers of dysplastic ducts than non-CCA cases (P<0.0001). The relative frequency of papillary (44%) versus flat (56%) dysplasia did not differ between CCA and non-CCA cases. Overall, intestinal metaplasia was a significant predictor of bile duct dysplasia (P=0.0005) and CCA (P=0.013), low-grade dysplasia predicted high-grade dysplasia (P<0.0001) and CCA (P=0.0004), and high-grade dysplasia predicted CCA (P<0.0001). Among the clinical parameters, there were no significant differences in age, sex, history of inflammatory bowel disease, or PSC duration, but patients transplanted for CCA were less likely to have cirrhosis (60% vs. 86%, P=0.008). These data strongly support a metaplasia-low-grade dysplasia-high-grade dysplasia-carcinoma sequence in PSC-associated CCA, and underscore the known lack of relationship between patient age and PSC duration in the development of CCA. Even in the absence of CCA, bile duct dysplasia is still a relatively frequent finding, seen at least focally in 36% of benign end-stage PSC explants. Dysplasia, however, is generally confined to large and septal-size bile ducts and its presence may not be recognized unless multiple sections specifically targeted to the biliary tree are examined.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, about one-third of patients with biliary dysplasia have been reported not to have CCA on follow-up and the time interval for progression from dysplasia to carcinoma is unpredictable.342”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [342]
In the citing paper
“Biliary dysplasia of any grade has been reported in 83% of explant livers with PSC-CCA, compared with 36% of those without CCA and the dysplastic changes are often multifocal.342”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [342]
Citations
Cites
Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis
Burak, K., Angulo, P., Pasha, T. M., Egan, K., Petz, J., & Lindor, K. D. (2004) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04067.x · Cited by 557 · cited 2×
“With the advent of better imaging techniques and the documentation of PSC for years before the development of CCA, it is now widely accepted that PSC is a major risk factor for CCA, which develops in 7% to 30% of these patients.(4,7,18,21,27) Recent work has suggested that biliary carcinogenesis in PSC arises through…”
BackgroundMethodTischendorf, J. J. W., Hecker, H., Krüger, M., Manns, M. P., & Meier, P. N. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00872.x · Cited by 413 · cited 1×
“With the advent of better imaging techniques and the documentation of PSC for years before the development of CCA, it is now widely accepted that PSC is a major risk factor for CCA, which develops in 7% to 30% of these patients.(4,7,18,21,27) Recent work has suggested that biliary carcinogenesis in PSC arises through…”
MethodCholangiocarcinoma in patients with primary sclerosing cholangitis: A multicenter case-control study
Chalasani, N., Baluyut, A., Ismail, A., Zaman, A., Sood, G., Ghalib, R., McCashland, T. M., Reddy, R. K., Zervos, X., Anbari, M. A., et al. (2000) · Hepatology · doi:10.1002/hep.510310103 · Cited by 336 · cited 1×
“CCA risk also does not seem to correlate with clinical indices of PSC severity.(8) Similarly, we did not observe any relationship between the degree of bile duct inflammation and the presence or absence of metaplastic or dysplastic epithelium.”
BackgroundLudwig, J., Barham, S. S., Larusso, N. F., Elveback, L. R., Wiesner, R. H., & McCall, J. T. (1981) · Hepatology · doi:10.1002/hep.1840010612 · Cited by 328
The natural history of small-duct primary sclerosing cholangitis
Björnsson, E., Olsson, R., Bergquist, A., Lindgren, S., Braden, B., Chapman, R. W., Boberg, K. M., & Angulo, P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.042 · Cited by 305 · cited 1×
“With the advent of better imaging techniques and the documentation of PSC for years before the development of CCA, it is now widely accepted that PSC is a major risk factor for CCA, which develops in 7% to 30% of these patients.(4,7,18,21,27) Recent work has suggested that biliary carcinogenesis in PSC arises through…”
MethodZen, Y., Adsay, N. V., Bardadin, K., Colombari, R., Ferrell, L., Haga, H., Hong, S.-M., Hytiroglou, P., Klöppel, G., Lauwers, G. Y., et al. (2007) · Modern Pathology · doi:10.1038/modpathol.3800788 · Cited by 292 · cited 1×
“In addition to classification of bile ducts as metaplastic, low-grade dysplasia, or high-grade dysplasia, biliary alterations were also classified according to the recently-described nomenclature for biliary intraepithlelial neoplasia (BilIN) grades 1, 2, and 3.(31) Briefly, BilIN-1 included ducts with mucinous metapl…”
MethodBergquist, A., Glaumann, H., Persson, B., & Broomé, U. (1998) · Hepatology · doi:10.1002/hep.510270201 · Cited by 281 · cited 1×
“It has been observed that one-third to one-half of PSC-associated CCAs are found within the first year of the patients’ PSC diagnosis,(20) and thus the mean duration of PSC in CCA cases is either the same or slightly lower than non-CCA cases.(2,7) CCA risk also does not seem to correlate with clinical indices of PSC s…”
BackgroundWee, A., Ludwig, J., Coffey, R. J., LaRusso, N. F., & Wiesner, R. H. (1985) · Human Pathology · doi:10.1016/s0046-8177(85)80158-1 · Cited by 191
Lewis, J. T., Talwalkar, J. A., Rosen, C. B., Smyrk, T. C., & Abraham, S. C. (2007) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213435.99492.8a · Cited by 187
Self-citationAnatomic and molecular pathology of intrahepatic cholangiocarcinoma
Nakanuma, Y., Harada, K., Ishikawa, A., Zen, Y., & Sasaki, M. (2003) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-002-0729-3 · Cited by 121 · cited 3×
“Some earlier studies have noted that intrahepatic bile duct dysplasia preferentially involves the large and septal-sized ducts whereas interlobular bile ducts are typically unaffected.(23,28) This finding is observed in both PSC-associated and non-PSC-associated biliary dysplasia, and suggests that sampling of periphe…”
BackgroundPrecancerous lesions of intrahepatic cholangiocarcinoma
Shimonishi, T., Sasaki, M., & Nakanuma, Y. (2000) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s005340070002 · Cited by 107 · cited 2×
“Recent work has suggested that biliary carcinogenesis in PSC arises through a hyperplasia-dysplasiacarcinoma sequence.(23,25) Bile duct dysplasia has been reported in variable percentages of PSC cases complicated by CCA.”
BackgroundAn update on primary sclerosing cholangitis
Maggs, J. R., & Chapman, R. W. (2008) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3282f9e239 · Cited by 106
Biliary dysplasia as a marker of cholangiocarcinoma in primary sclerosing cholangitis
Fleming, K. A., Boberg, K. M., Glaumann, H., Bergquist, A. M., Smith, D., & Clausen, O. P. F. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00034-9 · Cited by 100 · cited 2×
“Some case reports(6,11,19,30) and small series(2,3,29) have reported relatively high rates of bile duct dysplasia in patients with PSC who either have or subsequently develop CCA, whereas other studies find dysplasia in only a minority of livers with PSC-associated CCA.(10) Further, biliary dysplasia has been reported…”
BackgroundTaniai, M., Higuchi, H., Burgart, L. J., & Gores, G. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.36021 · Cited by 99
Bergquist, A. M., Glaumann, H., Stal, P. I., Wang, G., & Broomé, U. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00775.x · Cited by 61 · cited 1×
“In the CCA setting, Bergquist et al found dysplasia away from the main tumor in 5 of 8 (63%) livers that were examined at autopsy or liver transplant,(2) and in 7 of 12 (58%) livers in a subsequent study.(3) Fleming et al(10) reported dysplasia in only 5 of 26 (19%) of PSC patients who had CCA or developed CCA within…”
BackgroundCholangiocarcinoma Complicating Primary Sclerosing Cholangitis: A 24-Year Experience
Morris-Stiff, G., Bhati, C. S., Olliff, S. P., Hübscher, S. G., Gunson, B. K., Mayer, D., Mirza, D. F., Buckels, J. A. C., & Bramhall, S. R. (2008) · Digestive Surgery · doi:10.1159/000128169 · Cited by 61 · cited 1×
“With the advent of better imaging techniques and the documentation of PSC for years before the development of CCA, it is now widely accepted that PSC is a major risk factor for CCA, which develops in 7% to 30% of these patients.(4,7,18,21,27) Recent work has suggested that biliary carcinogenesis in PSC arises through…”
MethodDeHaan, R. D., Kipp, B. R., Smyrk, T. C., Abraham, S. C., Roberts, L. R., & Halling, K. C. (2007) · Human Pathology · doi:10.1016/j.humpath.2006.09.004 · Cited by 58 · cited 14×
“%) biopsy specimens from patients with concurrent or subsequent CCA.”
BackgroundSelf-citationBile Duct Dysplasia in the Setting of Chronic Hepatitis C and Alcohol Cirrhosis
Torbenson, M. S., Yeh, M. M., & Abraham, S. C. (2007) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318053d122 · Cited by 53 · cited 2×
“Some earlier studies have noted that intrahepatic bile duct dysplasia preferentially involves the large and septal-sized ducts whereas interlobular bile ducts are typically unaffected.(23,28) This finding is observed in both PSC-associated and non-PSC-associated biliary dysplasia, and suggests that sampling of periphe…”
BackgroundSelf-citationExpression of p53 and PCNA in Cholangiocarcinoma and Primary Sclerosing Cholangitis
Batheja, N. O., Suriawinata, A. A., Saxena, R., Ionescu, G., Schwartz, M., & Thung, S. N. (2000) · Modern Pathology · doi:10.1038/modpathol.3880231 · Cited by 51
Superficial thrombophlebitis, dysplasia, and cholangiocarcinoma in primary sclerosing cholangitis
Martins, E. B., Fleming, K. A., Garrido, M. C., Hine, K. R., & Chapman, R. W. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90182-1 · Cited by 49
The Extrahepatic Bile Duct Lesions in End-Stage Primary Sclerosing Cholangitis
Katabi, N., & Albores‐Saavedra, J. (2003) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200303000-00008 · Cited by 46
Papillary bile duct dysplasia in primary sclerosing cholangitis
Ludwig, J., Wahlstrom, H. E., Batts, K. P., & Wiesner, R. H. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90343-w · Cited by 43 · cited 2×
“Nevertheless, the presence of papillary and/or widespread intraductal dysplasia resembling IPMN has also been noted in several case reports of PSC both with and without invasive CCA.(5,6,11,17,30) In 2 of these reports, the invasive carcinomas were of mucinous or colloid types, further reinforcing the resemblance to p…”
BackgroundResultAdvances in the diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis
Luna, L. E. M., & Gores, G. J. (2006) · Liver Transplantation · doi:10.1002/lt.20938 · Cited by 38
Successful liver transplantation for hilar cholangiocarcinoma
Heimbach, J. K. (2008) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3282f706ce · Cited by 33
Bile duct carcinoma and biliary tract dysplasia in chronic ulcerative colitis.
Haworth, A. C., Manley, P. N., Groll, A., & Pace, R. F. (1989) · PubMed · Cited by 33
Definition and pathology of primary sclerosing cholangitis
Nakanuma, Y., Harada, K., Katayanagi, K., Tsuneyama, K., & Sasaki, M. (1999) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s005340050127 · Cited by 29 · cited 1×
“We evaluated the following histologic features and recorded the number of bile duct profiles with each feature: (1) bile duct metaplasia (intestinal, mucinous, pyloric, pancreatic acinar, or squamous); (2) biliary dysplasia (low-grade or high-grade; papillary or flat architecture); and (3) invasive CCA; the degree of…”
MethodBu-Ghanim, M., Suriawinata, A. A., Killackey, M. T., Schwartz, M., Jaffe, D. L., & Fiel, M. I. (2004) · Seminars in Liver Disease · doi:10.1055/s-2004-828897 · Cited by 14 · cited 2×
“In 2 of these reports, the invasive carcinomas were of mucinous or colloid types, further reinforcing the resemblance to pancreatic IPMN.(6,30) The epidemiologic findings in our patients closely mirror earlier studies of PSC-associated CCA.”
ResultBoberg, K. M., Jebsen, P., Clausen, O. P. F., Aabakken, L., Brekke, I. B., & Schrumpf, E. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00326-x · Cited by 13 · cited 14×
“%) biopsy specimens from patients with concurrent or subsequent CCA.”
ResultInfluentialDissecting the genetic susceptibility for cholangiocarcinoma in primary sclerosing cholangitis
Lazaridis, K. N. (2007) · Hepatology · doi:10.1002/hep.22100 · Cited by 8
Mucin-producing Bile Duct Carcinoma Arising from Primary Sclerosing Cholangitis: A Case Report
Yokomuro, S., Arima, Y., Mizuguchi, Y., Shimizu, T. M., Kawahigashi, Y., Kannda, T., Arai, M., Uchida, E., Akimaru, K., & Tajiri, T. (2007) · Journal of Nippon Medical School · doi:10.1272/jnms.74.61 · Cited by 6 · cited 2×
“In 2 of these reports, the invasive carcinomas were of mucinous or colloid types, further reinforcing the resemblance to pancreatic IPMN.(6,30) The epidemiologic findings in our patients closely mirror earlier studies of PSC-associated CCA.”
ResultMenon, K. V. N. (2006) · Liver Transplantation · doi:10.1002/lt.20937 · Cited by 4
Cited by
Razumilava, N., & Gores, G. J. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61903-0 · Cited by 1,729
Primary sclerosing cholangitis – a comprehensive review
Karlsen, T. H., Folseraas, T., Thorburn, D., & Vesterhus, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.022 · Cited by 868
“S e m in a r JOURNAL OF HEPATOLOGY (elevated levels may be observed with cholangitis or other malignancies).207 Genetic variants in the fucosyltransferases 2 and 3 (FUT2/FUT3) influence CA19-9 levels.208 MRI and computerised tomography may visualise early features of CCA in PSC, but difficulties in distinguishing infl…”
BackgroundInfluentialEASL Clinical Practice Guidelines on sclerosing cholangitis
Chazouilleres, O., Beuers, U., Bergquist, A., Karlsen, T. H., Levy, C., Samyn, M., Schramm, C., & Trauner, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.05.011 · Cited by 419
Epidemiology of cholangiocarcinoma
Bergquist, A., & von Seth, E. (2015) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2015.02.003 · Cited by 400
“About one third of patients exhibiting biliary dysplasia will not have CCA on follow-up [56,79].”
Anatomical, histomorphological and molecular classification of cholangiocarcinoma
Kendall, T., Verheij, J., Gaudio, E., Evert, M., Guido, M., Goeppert, B., & Carpino, G. (2019) · Liver International · doi:10.1111/liv.14093 · Cited by 350
Metadata
- Authors
- Lewis, J. T., Talwalkar, J. A., Rosen, C. B., Smyrk, T. C., & Abraham, S. C.
- Affiliations
- DeKalb Medical Center (US)
- Mayo Clinic (US)
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Lewis, Jason T.
- Venue
- American Journal of Surgical Pathology
- Published
- 2010-01
- Volume
- 34
- Issue
- 1
- Pages
- 27-34
- ISSN
- 0147-5185 (ISSN-L)
- OpenAlex
- W1985358323
- Cited by
- 122
- References
- 31
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 5 · 2023: 5 · 2022: 7 · 2021: 8 · 2020: 5 · 2019: 8 · 2018: 5 · 2017: 8 · 2016: 12 · 2015: 10 · 2014: 11 · 2013: 6 · 2012: 4
- FWCI
- 4.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Surgical Pathology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Cholangiocarcinoma and Gallbladder Cancer Studies
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Keywords
- primary sclerosing cholangitis, cholangiocarcinoma, biliary dysplasia, biliary intraepithelial neoplasia, intestinal metaplasia, mucinous metaplasia, pyloric metaplasia, liver transplantation, liver explants, inflammatory bowel disease, cholangiocarcinoma risk
- MeSH terms
- Adolescent, Adult, Aged, Bile Duct Neoplasms, Bile Ducts, Intrahepatic, Female, Humans, Male, Metaplasia, Middle Aged, Precancerous Conditions, Retrospective Studies, Cholangitis, Sclerosing, Cholangiocarcinoma, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.